Meng Cao

747 total citations
27 papers, 449 citations indexed

About

Meng Cao is a scholar working on Molecular Biology, Cell Biology and Immunology. According to data from OpenAlex, Meng Cao has authored 27 papers receiving a total of 449 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 6 papers in Cell Biology and 5 papers in Immunology. Recurrent topics in Meng Cao's work include RNA modifications and cancer (7 papers), Cancer-related molecular mechanisms research (5 papers) and Cancer-related gene regulation (3 papers). Meng Cao is often cited by papers focused on RNA modifications and cancer (7 papers), Cancer-related molecular mechanisms research (5 papers) and Cancer-related gene regulation (3 papers). Meng Cao collaborates with scholars based in China, United States and Hong Kong. Meng Cao's co-authors include Kuirong Jiang, Xinquan Wu, Baobao Cai, Pengfei Wu, Zipeng Lu, Ri Cui, Tianfang Xia, Xiaokun Li, Yi Miao and Guodong Shi and has published in prestigious journals such as PLoS ONE, Oncogene and FEBS Letters.

In The Last Decade

Meng Cao

24 papers receiving 448 citations

Peers

Countries citing papers authored by Meng Cao

Since Specialization

Citations

This map shows the geographic impact of Meng Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meng Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meng Cao more than expected).

Fields of papers citing papers by Meng Cao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meng Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meng Cao. The network helps show where Meng Cao may publish in the future.

Co-authorship network of co-authors of Meng Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Meng Cao. A scholar is included among the top collaborators of Meng Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meng Cao. Meng Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Peptide-functionalized gold nanostars-assisted single-cell Raman spectra for molecular analysis of tumor metastasis based on cancer stem cells 2025 ·Talanta ·Zhiyi Peng, Han Yao, Junqi Li, (unknown), Guoguang Chen, Meng Cao, (unknown)	0
2	CEP55 Promotes Acral Melanoma Progression via MAPK Pathway and Predicts Survival Following Immunotherapy 2025 ·Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics ·Meng Cao, Rundong Zhang, (unknown), (unknown), Zongbo Qiu, Dongqing Li, Lin Tong, Yan Wang	0
3	Hypoxia induced cellular and exosomal RPPH1 promotes breast cancer angiogenesis and metastasis through stabilizing the IGF2BP2/FGFR2 axis 2024 ·Oncogene ·(unknown), Jing Yang, (unknown), Qianqian Yin, (unknown), (unknown), Yue Yang, (unknown), Meng Cao, (unknown), Yi Pan	8
4	Effects of an external static EF on the conformational transition of 5-HT1A receptor: A molecular dynamics simulation study 2024 ·Biophysical Chemistry ·(unknown), (unknown), (unknown), (unknown), Meng Cao, Qingwen Zhang, Yu Zou	2
5	Adverse effect of assisted reproductive technology-related hyperoestrogensim on the secretion and absorption of uterine fluid in superovulating mice during the peri-implantation period 2023 ·Frontiers in Endocrinology ·(unknown), Yuan Zhang, Meng Cao, Xiang Yu, Gao Li, Lianju Qin, Wei Wu, Yugui Cui, Jiayin Liu	2
6	Pan‐cancer analyses reveal multi‐omic signatures and clinical implementations of the forkhead‐box gene family 2023 ·Cancer Medicine ·Xiaoman Bi, (unknown), (unknown), (unknown), Liyang Chen, (unknown), Meng Cao, (unknown), (unknown), Hong Wang, Wu-Ping Zheng, Deng Wu, Shaojiang Zheng, Kongning Li	3
7	INSM1 promotes breast carcinogenesis by regulating C-MYC. 2023 ·PubMed ·(unknown), Yulu Sun, Zheying Liu, Yin Zhang, Meng Cao, Wei Wang, Jinqiu Tao, Yongzhong Yao	4
8	m6A Methyltransferase METTL3 Promotes the Progression of Primary Acral Melanoma via Mediating TXNDC5 Methylation 2022 ·Frontiers in Oncology ·(unknown), Meng Cao, (unknown), Qian Zhang, Guoqiang Zhang, (unknown), Liang Zhao, Qiang Wang, Fang Fang, Yan Wang, Jianfang Sun	10
9	Determination of 30 Trace Elements in Rice Based on ICP-MS/MS 2021 ·食品工业科技 ·(unknown), (unknown), (unknown), (unknown), Meng Cao, Wang Yan, Dong Wang	0
10	Oncolytic Adenovirus H101 Synergizes with Radiation in Cervical Cancer Cells 2021 ·Current Cancer Drug Targets ·(unknown), (unknown), Xiang Li, (unknown), Ying Wang, Meng Cao, Nana Zhang, Hongwei Chen, (unknown), (unknown)	8
11	RANBP1 promotes colorectal cancer progression by regulating pre-miRNA nuclear export via a positive feedback loop with YAP 2021 ·Oncogene ·Dandan Zheng, Meng Cao, (unknown), Xin Xia, Chunchun Zhi, (unknown), (unknown), Xiaoqin Yuan	16
12	DUOX2 As a Potential Prognostic Marker which Promotes Cell Motility and Proliferation in Pancreatic Cancer 2021 ·BioMed Research International ·Meng Cao, Pengbo Zhang, Pengfei Wu, Qun Chen, Wanli Ge, Guodong Shi, Jie Yin, Baobao Cai, (unknown), Yi Miao, Kuirong Jiang	4
13	Dissecting the Role of the FGF19-FGFR4 Signaling Pathway in Cancer Development and Progression 2020 ·Frontiers in Cell and Developmental Biology ·Yanan Liu, Meng Cao, Yuepiao Cai, Xiaokun Li, Chengguang Zhao, Ri Cui	64
14	miR-196b-5p-mediated downregulation of FAS promotes NSCLC progression by activating IL6-STAT3 signaling 2020 ·Cell Death and Disease ·Xiangjie Huang, (unknown), Xinping Zhu, Yun Yu, Meng Cao, Xiaodong Zhang, Shaotang Li, Wangyu Zhu, Fengjiao Wu, Xiaohui Zheng, Libo Jin, Congying Xie, Xiaoying Huang, Peng Zou, Xiaokun Li, Ri Cui	29
15	Neferine induces apoptosis by modulating the ROS‑mediated JNK pathway in esophageal squamous cell carcinoma 2020 ·Oncology Reports ·Kang An, Yuehan Zhang, Yingjiao Liu, (unknown), (unknown), Meng Cao, (unknown), (unknown), (unknown), (unknown)	22
16	Shp2 expression is upregulated in cervical cancer, and Shp2 contributes to cell growth and migration and reduces sensitivity to cisplatin in cervical cancer cells 2019 ·Pathology - Research and Practice ·Meng Cao, Dan Gao, Nana Zhang, (unknown), Ying Wang, (unknown), (unknown)	13
17	The RNA m6A methyltransferase METTL3 promotes pancreatic cancer cell proliferation and invasion 2019 ·Pathology - Research and Practice ·Tianfang Xia, Xinquan Wu, Meng Cao, Pengbo Zhang, Guodong Shi, Jingjing Zhang, Zipeng Lu, Pengfei Wu, Baobao Cai, Yi Miao, Kuirong Jiang	125
18	Benzene Exposure Alters Expression of Enzymes Involved in Fatty Acid β-Oxidation in Male C3H/He Mice 2016 ·International Journal of Environmental Research and Public Health ·Rongli Sun, Meng Cao, Juan Zhang, (unknown), Haiyan Wei, Xing Meng, Lihong Yin, Yuepu Pu	35
19	Discovery and preliminary evaluation of 2-aminobenzamide and hydroxamate derivatives containing 1,2,4-oxadiazole moiety as potent histone deacetylase inhibitors 2015 ·European Journal of Medicinal Chemistry ·Jin Cai, Hongtao Wei, Kwon Ho Hong, Xiaoqing Wu, Meng Cao, (unknown), Lushen Li, Chunlong Sun, Junqing Chen, Min Ji	44
20	Murine Missing in Metastasis (MIM) Mediates Cell Polarity and Regulates the Motility Response to Growth Factors 2011 ·PLoS ONE ·Dan Yu, Xiaoguo H. Zhan, Shuqiong Niu, Irina Mikhailenko, Dudley K. Strickland, Jianwei Zhu, Meng Cao, Xi Zhan	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact